{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:18:47Z","timestamp":1694625527152},"reference-count":0,"publisher":"Hogrefe Publishing Group","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2004,3,1]]},"abstract":"<jats:p> L'ost\u00e9oporose et ses manifestations fracturaires sont des complications fr\u00e9quentes et s\u00e9v\u00e8res de la corticoth\u00e9rapie. L'os trab\u00e9culaire est principalement affect\u00e9, avec une diminution de la formation et une acc\u00e9l\u00e9ration de la r\u00e9sorption osseuses. La pr\u00e9vention de l'ost\u00e9oporose cortisonique passe par des mesures g\u00e9n\u00e9rales telles qu'une suppl\u00e9mentation en calcium et en vitamine D, un apport prot\u00e9ique suffisant, un exercice physique r\u00e9gulier, et par des mesures sp\u00e9cifiques faisant appel aux substances utilis\u00e9es dans l'ost\u00e9oporose primaire. Ce sont les bisphosphonates qui, par leur m\u00e9canisme d'action d'inhibition de l'ost\u00e9or\u00e9sorption et par leurs r\u00e9sultats favorables dans cette indication, avec augmentation de la densit\u00e9 min\u00e9rale osseuse et r\u00e9duction de l'incidence des fractures vert\u00e9brales, s'imposent comme premier choix. <\/jats:p>","DOI":"10.1024\/0369-8394.93.11.407","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T12:10:28Z","timestamp":1138709428000},"page":"407-414","source":"Crossref","is-referenced-by-count":0,"title":["Pr\u00e9vention de l'ost\u00e9oporose cortisonique"],"prefix":"10.1024","volume":"93","author":[{"family":"Trombetti","sequence":"first","affiliation":[{"name":"Service des Maladies Osseuses (Centre collaborateur de l'OMS pour la Pr\u00e9vention de l'Ost\u00e9oporose), D\u00e9partement de R\u00e9habilitation et G\u00e9riatrie, H\u00f4pitaux Universitaires de Gen\u00e8ve"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ferrari","sequence":"additional","affiliation":[{"name":"Service des Maladies Osseuses (Centre collaborateur de l'OMS pour la Pr\u00e9vention de l'Ost\u00e9oporose), D\u00e9partement de R\u00e9habilitation et G\u00e9riatrie, H\u00f4pitaux Universitaires de Gen\u00e8ve"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Stoermann-Chopard","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, D\u00e9partement de M\u00e9decine Interne, H\u00f4pitaux Universitaires de Gen\u00e8ve"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Rizzoli","sequence":"additional","affiliation":[{"name":"Service des Maladies Osseuses (Centre collaborateur de l'OMS pour la Pr\u00e9vention de l'Ost\u00e9oporose), D\u00e9partement de R\u00e9habilitation et G\u00e9riatrie, H\u00f4pitaux Universitaires de Gen\u00e8ve"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0369-8394.93.11.407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T11:15:03Z","timestamp":1652008503000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0369-8394.93.11.407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,1]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,3,1]]}},"alternative-id":["10.1024\/0369-8394.93.11.407"],"URL":"https:\/\/doi.org\/10.1024\/0369-8394.93.11.407","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,1]]}}}